BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 22575297)

  • 1. Use of rate control medication before cardioversion of recent-onset atrial fibrillation or flutter in the emergency department is associated with reduced success rates.
    Blecher GE; Stiell IG; Rowe BH; Lang E; Brison RJ; Perry JJ; Clement CM; Borgundvaag B; Langhan T; Magee K; Stenstrom R; Birnie D; Wells GA
    CJEM; 2012 May; 14(3):169-77. PubMed ID: 22575297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the Ottawa Aggressive Protocol with rapid discharge of emergency department patients with recent-onset atrial fibrillation or flutter.
    Stiell IG; Clement CM; Perry JJ; Vaillancourt C; Symington C; Dickinson G; Birnie D; Green MS
    CJEM; 2010 May; 12(3):181-91. PubMed ID: 20522282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.
    Kukendrarajah K; Ahmad M; Carrington M; Ioannou A; Taylor J; Razvi Y; Papageorgiou N; Mead GE; Nevis IF; D'Ascenzo F; Wilton SB; Lambiase PD; Morillo CA; Kwong JS; Providencia R
    Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013255. PubMed ID: 38828867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibutilide Effectiveness and Safety in the Cardioversion of Atrial Fibrillation and Flutter in the Community Emergency Department.
    Vinson DR; Lugovskaya N; Warton EM; Rome AM; Stevenson MD; Reed ME; Nagam MR; Ballard DW;
    Ann Emerg Med; 2018 Jan; 71(1):96-108.e2. PubMed ID: 28969929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of pad placement for electrical cardioversion of atrial fibrillation/flutter: a systematic review.
    Kirkland S; Stiell I; AlShawabkeh T; Campbell S; Dickinson G; Rowe BH
    Acad Emerg Med; 2014 Jul; 21(7):717-26. PubMed ID: 25117151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in management of recent-onset atrial fibrillation and flutter among academic hospital emergency departments.
    Stiell IG; Clement CM; Brison RJ; Rowe BH; Borgundvaag B; Langhan T; Lang E; Magee K; Stenstrom R; Perry JJ; Birnie D; Wells GA
    Ann Emerg Med; 2011 Jan; 57(1):13-21. PubMed ID: 20864213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors predicting maintenance of sinus rhythm after direct current cardioversion of atrial fibrillation and flutter: a reanalysis with recently acquired data.
    Arnar DO; Danielsen R
    Cardiology; 1996; 87(3):181-8. PubMed ID: 8725311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Between- and within-site variation in medication choices and adverse events during procedural sedation for electrical cardioversion of atrial fibrillation and flutter.
    Clinkard D; Stiell I; Lang E; Rose S; Clement C; Brison R; Rowe BH; Borgundvaag B; Langhan T; Magee K; Stenstrom R; Perry JJ; Birnie D; Wells G; McRae A
    CJEM; 2018 May; 20(3):370-376. PubMed ID: 28587704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidemiology and management of recent-onset atrial fibrillation and flutter presenting to the Emergency Department.
    Hamilton A; Clark D; Gray A; Cragg A; Grubb N;
    Eur J Emerg Med; 2015 Jun; 22(3):155-61. PubMed ID: 25203594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, controlled comparison of electrical versus pharmacological cardioversion for emergency department patients with acute atrial flutter.
    Stiell IG; Sivilotti MLA; Taljaard M; Birnie D; Vadeboncoeur A; Hohl CM; McRae AD; Morris J; Mercier E; Macle L; Brison RJ; Thiruganasambandamoorthy V; Rowe BH; Borgundvaag B; Clement CM; Brinkhurst J; Brown E; Nemnom MJ; Wells GA; Perry JJ
    CJEM; 2021 May; 23(3):314-324. PubMed ID: 33959925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter.
    Stiell IG; Clement CM; Symington C; Perry JJ; Vaillancourt C; Wells GA
    Acad Emerg Med; 2007 Dec; 14(12):1158-64. PubMed ID: 18045891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety in pharmacological cardioversion of recent-onset atrial fibrillation: a propensity score matching to compare amiodarone vs class IC antiarrhythmic drugs.
    Bonora A; Turcato G; Franchi E; Taioli G; Dilda A; Zerman G; Maccagnani A; Pistorelli C; Olivieri O
    Intern Emerg Med; 2017 Sep; 12(6):853-859. PubMed ID: 27384766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation.
    Volgman AS; Carberry PA; Stambler B; Lewis WR; Dunn GH; Perry KT; Vanderlugt JT; Kowey PR
    J Am Coll Cardiol; 1998 May; 31(6):1414-9. PubMed ID: 9581743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioversion of Atrial Fibrillation (RHYTHM-AF) International Registry in Poland.
    Kiliszek M; Opolski G; Włodarczyk P; Dąbrowski R; Ponikowski P
    Cardiol J; 2014; 21(5):484-91. PubMed ID: 24526513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Termination of recent-onset atrial fibrillation/flutter in the emergency department: a sequential approach with intravenous ibutilide and external electrical cardioversion.
    Domanovits H; Schillinger M; Thoennissen J; Nikfardjam M; Janata K; Brunner M; Laggner AN
    Resuscitation; 2000 Aug; 45(3):181-7. PubMed ID: 10959017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, safety, and determinants of conversion of atrial fibrillation and flutter with oral amiodarone.
    Tieleman RG; Gosselink AT; Crijns HJ; van Gelder IC; van den Berg MP; de Kam PJ; van Gilst WH; Lie KI
    Am J Cardiol; 1997 Jan; 79(1):53-7. PubMed ID: 9024736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy.
    Naccarelli GV; Dell'Orfano JT; Wolbrette DL; Patel HM; Luck JC
    Am J Cardiol; 2000 May; 85(10A):36D-45D. PubMed ID: 10822039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
    Joseph AP; Ward MR
    Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes for Emergency Department Patients With Recent-Onset Atrial Fibrillation and Flutter Treated in Canadian Hospitals.
    Stiell IG; Clement CM; Rowe BH; Brison RJ; Wyse DG; Birnie D; Dorian P; Lang E; Perry JJ; Borgundvaag B; Eagles D; Redfearn D; Brinkhurst J; Wells GA
    Ann Emerg Med; 2017 May; 69(5):562-571.e2. PubMed ID: 28110987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
    Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A
    Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.